Joseph Truluck - Chief Financial Officer at ADIAL PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
ADIL on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Joseph Truluck since 08 Aug 2025

Reported holdings for Joseph Truluck in ADIAL PHARMACEUTICALS, INC.

Form 4 holding Chief Financial Officer

ADIAL PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
265,139
Estimated value
$111,411
Report date
23 May 2023
Price
$0.4202
Ownership
Direct
Form 4 holding Chief Financial Officer

ADIAL PHARMACEUTICALS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
25 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Joseph Truluck in ADIAL PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .